Jazz Pharma PTSD mid-stage trial fails to meet main goal, stock slips after hours
https://seekingalpha.com/news/4049426-jazz-pharma-ptsd-mid-stage-trial-fails-to-meet-main-goal-stock-slips-after-hours?source=feed_sector_healthcare
Dec 21, 2023 - Jazz Pharmaceuticals (JAZZ) on Thursday said a mid-stage trial of JZP150 for the treatment of PTSD failed to meet the main goal of the study. Read more here.
0
Swig named the official Soda Shop of Utah Jazz
https://www.nrn.com/regional-chains/swig-named-official-soda-shop-utah-jazz
Feb 06, 2024 - Take note, soda fans: when the ‘jazz win, you win’ with a free swig treat the day after the game
0
Jazz presents encouraging Phase 2 data for breast cancer treatment
https://seekingalpha.com/news/4044841-jazz-presents-encouraging-phase-2-data-for-breast-cancer-treatment?source=feed_sector_healthcare
Dec 08, 2023 - Jazz Pharmaceuticals presented positive Phase 2 data for zanidatamab in the treatment of metastatic HER2+/HR+ breast cancer at a medical meeting. Read more here.
0
71 Ben Graham January Value Stocks, 56 Jazzed Buys
https://seekingalpha.com/article/4660235-71-ben-graham-january-value-stocks-56-jazzed-buys?source=feed_all_articles
Dec 28, 2023 - Discover the latest insights in the financial world with this article covering value ranking strategies and top dividend stocks for investment. Click for the picks!
0
'We have scouts all over the world': Former NBA All-Star Danny Ainge takes a money shot for global talent
https://www.cnbc.com/2024/01/20/former-nba-all-star-danny-ainge-sees-demand-for-international-players.html
Jan 20, 2024 - Utah Jazz CEO Danny Ainge seeks to capitalize on heightened international interest in the NBA.
0
Avadel surges after royalty rate awarded to Jazz in patent dispute lower than requested (update)
https://seekingalpha.com/news/4075588-avadel-drops-after-jury-rules-in-favor-of-jazz-pharmaceuticals-in-patent-dispute?source=feed_sector_healthcare
Mar 04, 2024 - Avadels stock seesawed after a jury ruled in favor of Jazz Pharmaceuticals in a patent dispute over a sleep disorder drug.
0
Monfort Cos. wants to demolish El Chapultepec building. Historic preservationists are fighting it.
https://www.denverpost.com/2024/03/12/el-chapultepec-historic-preservation-petition-demolition-monfort-companies/
Mar 12, 2024 - Historic Denver this week filed an application for historic protection of the property at 1962 Market St.
0
JAZZ Boosts Oncology Pipeline With KRAS Inhibitor Program
https://www.zacks.com/stock/news/2223497/jazz-boosts-oncology-pipeline-with-kras-inhibitor-program?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2223497
Feb 08, 2024 - JAZZ inks a deal to acquire global rights to Redx Pharma's KRAS inhibitor program to strengthen its early-stage oncology pipeline.
0
Axsome (AXSM) Stock Falls Despite Q4 Earnings & Revenue Beat
https://www.zacks.com/stock/news/2229451/axsome-axsm-stock-falls-despite-q4-earnings-revenue-beat?cid=CS-ZC-FT-analyst_blog|earnings_article-2229451
Feb 21, 2024 - Axsome (AXSM) stock declines despite narrower-than-expected loss in the fourth quarter of 2023. Its sales also beat estimates.
0
Here's What Key Metrics Tell Us About Jazz (JAZZ) Q4 Earnings
https://www.zacks.com/stock/news/2233496/here-s-what-key-metrics-tell-us-about-jazz-jazz-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2233496
Feb 28, 2024 - The headline numbers for Jazz (JAZZ) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
0
Pages: 12
Page 1